Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints

Wednesday, November 18, 2020 Primary efficacy analysis demonstrates BNT162b2 to be 95% effective against COVID-19 beginning 28 days after the first dose;170 confirmed cases of COVID-19 were evaluated, with 162 observed in the placebo group versus 8 in the vaccine group Efficacy was consistent across age, gender, race and ethnicity demographics; observed efficacy in adults over 65 years of age […]

Continue reading »

Anti-Influenza Drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients

TOKYO — September 23, 2020 FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” (generic name: favipiravir, “Avigan”) conducted in Japan for patients with novel coronavirus infections (hereinafter “COVID-19”). The efficacy primary endpoint is time to negative conversion of detectable […]

Continue reading »

Scientists suggest new solution to the rare-disease problem

Thousands of rare diseases cumulatively affect millions of people across the globe, yet because each case is so rare doctors struggle to accurately diagnose and effectively treat individual patients. Every time a patient with an unspecified disorder walks into a new clinic or shows up in an emergency room, doctors must start from scratch. The patients often go through years […]

Continue reading »

Opioid industry presses for settlement as trial looms

With a trial looming, major drug distributors and manufacturers are pressing to settle thousands of claims against them related to the nation’s persistent opioid crisis. The companies are negotiating with state attorneys general as jury selection is expected to wrap up on Thursday in the first federal trial over an overdose epidemic that has claimed more than 400,000 American lives […]

Continue reading »

Sick Americans turning to medical pot for help

(HealthDay)—More Americans use marijuana to help them cope with an illness than just to get high, a new study finds. Nearly 46% of those who use pot say they do so because of a medical condition, compared with 22% who say they use marijuana for recreation. And only 36% of those with a medical problem say they use pot to […]

Continue reading »

Nancy Pelosi unveils an ambitious plan to lower drug prices

Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance. Pelosi, D-Calif., would empower Medicare to negotiate prices for the 250 costliest drugs, including insulin. Pharmaceutical companies that refuse to negotiate could face […]

Continue reading »

Oxycontin maker Purdue offers $10-12 bn for opioid claims: report

Purdue Pharma, whose prescription painkiller Oxycontin is blamed for much of the US opioid addiction epidemic, has offered $10-12 billion to settle thousands of claims against the company, NBC News reported Tuesday. The company, whose wealthy owners the Sackler family have come under international scorn for aggressively pushing the prescription drug, is in settlement talks in Cleveland, Ohio ahead of […]

Continue reading »
1 2 3